MENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi ...
Zacks.com on MSN
Here's Why You Should Add PacBio Stock to Your Portfolio
PACB is gaining from product development and strong Q3 results, with Revio and Vega driving growth, though longer purchasing ...
PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare that we ...
PacBio (PACB) announced innovations to its Revio and Vega platforms designed to lower sequencing costs, add new multiomic capabilities, and expand support for regulated research environments. The ...
(RTTNews) - Pacific Biosciences of California, Inc. (PACB), Monday announced that it has licensed novel deep learning-based DNA methylation detection technology from The Chinese University of Hong ...
PacBio’s 38.9% return over the past six months has outpaced the S&P 500 by 28.4%, and its stock price has climbed to $2.06 ...
StockStory.org on MSN
PacBio (PACB) stock is up, what you need to know
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.9% in the morning session after news from a previous session revealed that Cathie Wood's investment ...
The Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research MENLO PARK, Calif., Oct. 25, 2022 /PRNewswire/ -- ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product development. The optimism, led by decent fourth-quarter results, is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback